
March 20 (Reuters) - Sanofi SA SASY.PA:
PRESS RELEASE: SANOFI TO ACQUIRE DREN BIO’S BISPECIFIC MYELOID CELL ENGAGER FOR DEEP B-CELL DEPLETION, BROADENING IMMUNOLOGY PIPELINE
TO PAY $600 MILLION UP FRONT
DEAL INCLUDES POTENTIAL FUTURE PAYMENTS TOTALING $1.3 BILLION
TRANSACTION EXPECTED TO CLOSE DURING Q2 2025
TO FINANCE TRANSACTION WITH AVAILABLE CASH RESOURCES